Assenagon Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $299M | Buy |
|
|||||
|
2025
Q2 | $108M | Buy |
|
|||||
|
2025
Q1 | $101M | Sell |
|
|||||
|
2024
Q4 | $338M | Buy |
|
|||||
|
2024
Q3 | $145M | Buy |
|
|||||
|
2024
Q2 | $45.1M | Sell |
|
|||||
|
2024
Q1 | $135M | Buy |
|
|||||
|
2023
Q4 | $121M | Buy |
|
|||||
|
2023
Q3 | $70.3M | Sell |
|
|||||
|
2023
Q2 | $135M | Sell |
|
|||||
|
2023
Q1 | $195M | Sell |
|
|||||
|
2022
Q4 | $213M | Buy |
|
|||||
|
2022
Q3 | $192M | Buy |
|
|||||
|
2022
Q2 | $145M | Sell |
|
|||||
|
2022
Q1 | $211M | Buy |
|
|||||
|
2021
Q4 | $70.8M | Buy |
|
|||||
|
2021
Q3 | $12.6M | Sell |
|
|||||
|
2021
Q2 | $47.6M | Sell |
|
|||||
|
2021
Q1 | $58.8M | Sell |
|
|||||
|
2020
Q4 | $141M | Buy |
|
|||||
|
2020
Q3 | $33.8M | Sell |
|
|||||
|
2020
Q2 | $36.5M | Sell |
|
|||||
|
2020
Q1 | $183M | Buy |
|
|||||
|
2019
Q4 | $59M | Buy |
|
|||||
|
2019
Q3 | $4.84M | Buy |
|
|||||
|
2019
Q2 | $1.7M | Sell |
|
|||||
|
2019
Q1 | $12.6M | Sell |
|
|||||
|
2018
Q4 | $63.6M | Buy |
|
|||||
|
2018
Q3 | $36.9M | Sell |
|
|||||
|
2018
Q2 | $62M | Buy |
|
|||||
|
2018
Q1 | $24.8M | Sell |
|
|||||
|
2017
Q4 | $23.8M | Sell |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $1.21M | Buy |
|